Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2004101586) NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS
Latest bibliographic data on file with the International Bureau   
Pub. No.: WO/2004/101586 International Application No.: PCT/EP2004/005082
Publication Date: 25.11.2004 International Filing Date: 11.05.2004
IPC:
A61K 31/7048 (2006.01) ,C07H 17/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7048
having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
04
Heterocyclic radicals containing only oxygen as ring hetero atoms
08
Hetero rings containing eight or more ring members, e.g. erythromycins
Applicants:
ALIHODZIC, Sulejman [HR/HR]; HR (UsOnly)
FORREST, Andrew, Keith [GB/GB]; GB (UsOnly)
JARVEST, Richard, Lewis [GB/GB]; GB (UsOnly)
LAZAREVSKI, Gorjana [HR/HR]; HR (UsOnly)
PAVLOVIC, Drazen [HR/HR]; HR (UsOnly)
GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN, GB (AllExceptUS)
PLIVA - ISTRAZIVACKI INSTITUT D.O.O. [HR/HR]; Prilaz baruna Filipovica 29 10000 Zagreb, HR (AllExceptUS)
Inventors:
ALIHODZIC, Sulejman; HR
FORREST, Andrew, Keith; GB
JARVEST, Richard, Lewis; GB
LAZAREVSKI, Gorjana; HR
PAVLOVIC, Drazen; HR
Agent:
GLADWIN, Amanda, Rachel; GlaxoSmithKline Corporate Intellectual Property (CN925.1) 980 Great West Road Brentford Middlesex TW8 9GS, GB
Priority Data:
0310986.513.05.2003GB
Title (EN) NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS
(FR) NOUVEAU COMPOSES A CYCLE RAMIFIE EN 14 ET 15.
Abstract:
(EN) The present invention relates to 14- or 15-membered macrolides substituted at the 4' position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
(FR) La présente invention concerne des macrolides ramifiés en 14 et 15 substitués en position 4'', représentés par la formule (I) et des dérivés de ceux-ci répondant aux normes pharmaceutiques, et des processus de préparation et d'utilisation de ceux-ci dans la thérapie et la prophylaxie d'infections microbiennes topiques ou systémiques chez l'homme ou chez l'animal.
 front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)